Medicine composition for treating kidney-qi non-consolidation type primary glomerular hematuria

Abstract

The invention belongs to the technical field of medicine and particularly relates to a medicine composition for treating kidney-qi non-consolidation type primary glomerular hematuria. The medicine composition is composed of, by weight, 4-8 parts of greywhitehair raspberry fruits, 4-8 parts of rhizome gymnadenia, 4-8 parts of argy wormwood fruits, 4-8 parts of strobiles of cunninghamia lanceolata (lamb.) hook., 4-8 parts of rubus sachalinensis roots, 4-8 parts of wooden diaphragms of juglans regia L., 4-8 parts of hill gooseberries, 4-8 parts of fruit of terminalia bellirica (gaertn.) roxb., 4-8 parts of ginseng rhizomes, 4-8 parts of undulateleaf aralia, undulate aralia roots and 4-8 parts of licorice roots. All medicinal raw materials are combined to achieve the effects of tonifying kidney-qi and stopping bleeding through astringent therapy. The medicine composition can effectively improve clinical symptoms and body signs of patients, lower the number of red blood cells in urine, decrease urine protein and raise the glomerular filtration rate.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating primary glomerular hematuria of kidney qi deficiency type. Background technique [0002] Glomerular hematuria, also known as medical hematuria, is a group of glomerular hematuria with different etiologies and different pathogenesis, with hematuria (urinary malformed red blood cells > 8000 / mL, and the proportion > 75%) as the main clinical manifestation. disease. Because of its recurrent attacks, protracted and difficult to heal, most of them develop into chronic renal failure. Although the incidence of primary glomerular hematuria has not been reported, it is a very common clinical symptom. Clinical data in recent years have shown that IgA nephropathy is the most common cause of primary glomerular hematuria. It is common and is the most common primary glomerulonephritis in the Asia-Pacific region. In the past, simple...

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine is not clear about the pathogenesis of primary glomerular hematuria, and there is no effective treatment for it.

There are no drug reports for this type of primary glomerular hematuria